Skip to content

Efficacy of a Digital Nonattachment-Based Intervention for Post-traumatic Stress Symptoms: A Randomised Controlled Trial

Lindsay Tremblay, William van Gordon, James Elander

Mindfulness September 1, 2026 DOI: 10.1007/s12671-026-02872-0 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Preregistered Peer reviewed
Sample size 141
Population Adults meeting DSM-5 or ICD-11 criteria for post-traumatic stress disorder
Interventions Nonattachment for Post-Traumatic Stress (NPTS) Waitlist control
Duration 8-week intervention, follow-up at 20 weeks
Measures PTSD Checklist for DSM-5, Nonattachment Scale, Acceptance and Action Questionnaire-II, Five Facet Mindfulness Questionnaire
Topics PTSD
Registration NCT06683027
Key findings Compared with waitlist, NPTS produced significantly greater reductions in PTSD symptoms at 8 and 20 weeks with large between-group effect sizes, along with increased nonattachment and reduced psychological inflexibility; mediation analyses suggested these changes were associated with symptom reduction.

Abstract

Abstract Objectives Nonattachment, defined as the capacity to relate to internal experiences, identities, and external circumstances without clinging, avoidance, or over-identification, has been associated with reduced psychological distress and enhanced well-being, yet its deliberate cultivation within trauma-focused interventions remains underexplored. This study evaluated Nonattachment for Post-Traumatic Stress (NPTS), a co-created, self-guided digital intervention designed to cultivate nonattachment as a therapeutic process for individuals experiencing post-traumatic stress symptoms.

Method: A two-arm, parallel-group randomised controlled trial ( n = 141) compared NPTS with a waitlist control. Participants meeting DSM-5 or ICD-11 criteria for post-traumatic stress disorder (PTSD) were randomised to either NPTS or a waitlist control. NPTS is an eight-module, self-guided digital programme incorporating psychoeducation, guided contemplative and somatic practices, and structured reflection exercises designed to cultivate nonattachment. Outcomes were assessed at baseline, 8 weeks, and 20 weeks using the PTSD Checklist for DSM-5, Nonattachment Scale, Acceptance and Action Questionnaire-II, and Five Facet Mindfulness Questionnaire. Analyses followed CONSORT (2025) guidance and included intention-to-treat analyses using last observation carried forward, complete-case sensitivity analyses, and exploratory mediation analyses examining nonattachment and psychological flexibility.

Results: Compared with waitlist participants, intervention participants showed significantly greater reductions in PTSD symptoms at 8 weeks and 20 weeks, with large between-group effect sizes in intention-to-treat analyses. Participants in the intervention group also demonstrated increases in nonattachment and reductions in psychological inflexibility. Exploratory mediation analyses suggested that changes in nonattachment and psychological flexibility were associated with PTSD symptom reduction.

Conclusions: Findings provide evidence for the feasibility and potential efficacy of a co-created, nonattachment-based digital intervention for post-traumatic stress and support further investigation of nonattachment as a cultivable process within trauma-informed, second-generation mindfulness-based interventions. Preregistration This trial was pre-registered at Clinicaltrials.gov: NCT06683027.

Comparable studies

Other randomized controlled trials on PTSD, most cited first.

Study Year Design Participants
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Patients with severe PTSD, including those with comorbidities such as dissociation,... 2021 Randomized controlled trial n = 90
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Patients with treatment-resistant PTSD 2012 Randomized controlled trial n = 12

Citations in the library

Explore topics